Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... और पढ़ें
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734753) titled 'Impact of Alirocumab on Cardiovascular Events in Participants With Atherosclerotic Cardiova... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... और पढ़ें
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733128) titled 'Analgesia With Transdermal Buprenorphine Patch in Adults Undergoing Video-Assisted Thoracos... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... और पढ़ें
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07732543) titled 'Developing and Testing the Effectiveness of Smart Healthcare Assisted Individualized Sympto... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... और पढ़ें
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... और पढ़ें